Business Wire

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Healio

Study shows comparative outcomes of toric, non-toric versions of AcrySof IQ PanOptix IOL

Please provide your email address to receive an email when new articles are posted on . A prospective comparative case series of 50 patients implanted bilaterally ...
Yahoo Finance

Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery

BASEL, Switzerland, January 26, 2017 - Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof ® IQ PanOptix ® Toric presbyopia- and astigmatism-correcting ...
USA Today

What people probably don’t know about cataract surgery

Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...
Nasdaq

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
Finanznachrichten

Novartis International AG: Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery

Innovative AcrySof® IQ PanOptix® Toric intraocular lens (IOL) extends Alcon's trifocal PanOptix® IOL portfolio to a wider range of patients CE-marked in November 2016, this IOL offers excellent ...